Expeditors International of Wshngtn Inc vs Intuitive Surgical, Inc. — how do they compare? Expeditors International of Wshngtn Inc trades at $183.59 (market cap $23.04B), while Intuitive Surgical, Inc. trades at $402.23 (market cap $141.75B). The key difference: Intuitive Surgical, Inc. is far larger — about 6.2× Expeditors International of Wshngtn Inc's market cap, and Expeditors International of Wshngtn Inc pays a 0.91% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| EXPD | ISRG | |
|---|---|---|
Market Cap | $23.04B | $141.75B |
Sector | Industrials | Health |
52-Week High | $182.80 | $592.85 |
52-Week Low | $113.13 | $332.02 |
Enterprise Value | $22.57B | $136.53B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
EXPD trades at $182.11, up 1.74% today, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings of $2.03 per share, beating estimates, driven by airfreight and customs demand. Revenue for 2025 was $11.07B, with a net income margin of 7.63% and robust ROE of 42.6%. Recent news highlights growth from tariff policies but notes ocean freight contraction.
Outlook is mixed; earnings momentum and high profitability support upside, but analyst consensus is Hold with a $181.14 target, near current price. Risks include unsustainable growth from temporary factors and competitive pressures. The stock's valuation at a P/E of 25.79 appears fair given earnings beats, but caution is warranted if ocean freight weakness persists.
Intuitive Surgical (ISRG) trades at $403.95, up 2.69% on the day, reflecting strong momentum. The stock exhibits bullish technical signals with support at $398 and resistance at $403. Fundamentally, revenue grew to $10.06B in 2025 with a net income margin of 28.45%, though valuation ratios like a P/E of 46.01 suggest premium pricing. Recent quarters show consistent earnings beats, with Q2 2026 EPS of $2.80 exceeding expectations. News highlights analyst upgrades and robust adoption of the da Vinci 5 system.
Outlook remains positive driven by innovation and market expansion, but high valuation and competitive pressures pose risks. The consensus price target of $518.10 implies significant upside, supported by 68% buy ratings from analysts. Key risks include reliance on U.S. procedure growth and rising competition from Medtronic and Johnson & Johnson. Long-term growth prospects appear solid if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →